Millie
your market intelligence analyst
Search Results
378 results
Your search is now limited to «Breast Cancer» expert search.
PubMed News (NIH) 06/04/2020
Contributors : Matthew E Burow ; Kenneth Nephew ; Fang Fang ; Douglas R Busch ; Aaron Buechlein Series Type : Expression profiling by high throughput sequencing Organism : Homo sapiens. Depletion of ERK5 expression using the CRISPR/Cas9 system in MDA-MB-231 and Hs-578T cells resulted in loss of mesenchymal features, as observed through gene expression profile and cell morphology, and suppressed TNBC cell migration.
PubMed News (NIH) 06/04/2020
Contributors : Alexander S Roesler ; Elizabeth Lenkiewicz ; Smriti Malasi ; Lacey E Dobrolecki ; Michael T Lewis ; Karen S Anderson ; Michael T Barrett Series Type : Genome variation profiling by genome tiling array Organism : Homo sapiens. We applied DNA content flow cytometry to ten patient derived triple negative breast cancer (TNBC) xenografts (PDXs) from the Baylor College of Medicine (BCM).
Background and importance. Neoadjuvant chemotherapy has become the standard treatment for patients with inoperable locally advanced tumours, and it is also optional for operable stages. The literature reports rates of 20–30% and 56–66% for pathological complete response (pCR) in patients treated with combinations of anthracyclines and taxanes, and dual blockade of human epidermal growth factor receptor 2 (HER2), respectively. Aim and objectives. To assess the effectiveness of neoadjuvant chemotherapy in stage II/III breast cancer according to expression of HER2 and hormonal receptors (HR) based on pCR. Material and methods. A retrospective observational study was carried out between January 2016 and December 2018 in a second level hospital. Th.
In the HER2CLIMB study, patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer with brain metastases (BMs) showed statistically significant improvement in progression-free survival (PFS) with tucatinib.

Information Technologies

IT Markets

Business Issues

Companies - Public

Companies - Venture Funded

Analysts

Analyst Firms

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications